Status:
UNKNOWN
Influence of Catheter-based Renal Denervation in Diseases With Increased Sympathetic Activity
Lead Sponsor:
University Hospital, Saarland
Conditions:
Hypertension
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The study is aiming to document the long-term safety and effectiveness of renal denervation in patients with hypertension and other diseases characterized by elevated sympathetic drive. Catheter-based...
Detailed Description
Inclusion Criteria 1. Individual is 18 years of age. 2. Individual agrees to have all procedures performed, and is competent and willing to provide written, informed consent to participate in the reg...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Individual is 18 years of age.
- Individual agrees to have all procedures performed, and is competent and willing to provide written, informed consent to participate in the registry.
- Patient scheduled for renal sympathetic denervation using market-released device.
- Exclusion Criteria
- In the eyes of the treating physician, the renal artery anatomy would interfere with safe cannulation of the renal artery or meets local standards for surgical repair.
- Individual has any serious medical condition, which in the opinion of the treating physician may adversely affect the safety and/or effectiveness of the participant (i.e., patients with clinically significant peripheral vascular disease, abdominal aortic aneurysm, bleeding disorders such as thrombocytopenia, hemophilia, significant anemia, etc.).
Exclusion
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT01888315
Start Date
January 1 2011
End Date
January 1 2021
Last Update
June 27 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Saarland
Homburg/Saar, Germany, 66421